格隆汇12月19日丨美好医疗(301363.SZ)在投资者互动平台表示，脑机接口产品的成熟度和应用场景随 着下游客户产品的成熟和完善性能不断提高。公司正与下游脑机接口客户深入开展产品合作，协助客户 实现从实验室研发到批量出货的高效商业化转化，目前相关业务产生的收入规模较小。 ...

Core Insights - The recent successful experiment involving a paralyzed patient controlling an electric wheelchair and a robotic dog through an invasive brain-computer interface (BCI) marks a significant advancement in China's BCI research, moving beyond basic interaction capabilities to enhancing patients' real-life experiences [1][2] Group 1: Technological Advancements - The experiment demonstrates a shift from controlling symbols on a screen to interacting with physical entities, indicating a broader application of BCI technology [1] - The technology aims to restore dignity, autonomy, and social participation for patients, transforming their quality of life by enabling them to engage in everyday activities [1] Group 2: Policy and Development Path - China's development path in BCI is becoming clearer, with national ethical guidelines and multi-departmental initiatives promoting innovation while ensuring ethical standards [2] - The collaborative model of "research-clinical-industry" is accelerating the transition from scientific discovery to real-world benefits for patients [2] Group 3: Future Challenges - Despite the progress, challenges remain in ensuring the long-term safety, system stability, and affordability of invasive BCIs, as well as improving the precision of neural signal interpretation and human-machine interaction [2]

Core Viewpoint - The establishment of the Yangtze River Delta Brain-Computer Interface (BCI) Industry Innovation Alliance marks a significant step in advancing brain science research and its industrial applications in the region [1] Group 1: Industry Development - The Yangtze River Delta BCI Industry Innovation Alliance consists of 12 member units, aiming to enhance collaboration in the BCI sector [1] - The conference highlighted the importance of BCI as a key to unlocking the mysteries of the brain, with a focus on future industries such as biomedicine [1] - Nantong has implemented policies to accelerate the development of future industries, identifying biomedicine as one of the six main focus areas [1] Group 2: Clinical Research and Applications - Clinical research is identified as crucial for the practical application of BCI technology [1] - The newly formed alliance aims to bridge the gap between technology research and industrial transformation [1] - Collaboration with Jiangsu Provincial People's Hospital will establish a clinical research center to explore new clinical applications for invasive BCI technologies [1]

Group 1 - The brain-computer interface (BCI) industry in China is gaining significant attention, with multiple policies introduced at various levels of government to support its development [1][2] - Specific policies targeting BCI include the "Implementation Opinions on Promoting the Innovative Development of the BCI Industry" released in July and measures from Jiangxi Province to accelerate BCI technology and industry development [1] - The government is creating a multi-level policy system to support the entire BCI industry chain, aiming for high-quality development [1] Group 2 - The BCI industry is experiencing rapid advancements driven by policy support, with continuous technological iterations and expanding application scenarios [2] - Improvements in the safety and effectiveness of invasive BCI technologies and advancements in the precision and cost control of non-invasive technologies are notable [2] - The integration of BCI technology with artificial intelligence is transitioning from laboratory validation to large-scale application, indicating significant industrial potential [2] Group 3 - Despite the positive momentum, the BCI industry is still in its early stages and faces challenges related to technology, standards, and ethical safety [3] - To advance the industry, there is a need for core technology breakthroughs, particularly in high-precision EEG sensors and efficient encoding/decoding algorithms [3] - Collaboration between enterprises, universities, research institutions, and medical organizations is essential for cultivating interdisciplinary talent to enhance high-level talent supply [3]

资料显示，在脑机接口(BCI)领域，如何平衡"高性能"与"长期安全性"始终是产业化应用的核心课题。 脑虎科技此次实现突破的产品，凭借"全植入、全无线、全功能"的"三全"特征，或给行业带来新的解题 思路。记者从脑虎科技获悉，该产品是国内首款将所有核心模块(含电池)完全植入体内的脑机接口设 备。该设备采用"胸部电池"方案，将发热单元置于对温度更耐受的胸部皮下。在确保系统全功能运行的 同时，从物理层面根除了传统外露系统易导致的感染风险，从而提升了临床安全性。除全植入外，该产 品还集成了无线供能与数据传输，使患者彻底摆脱了体外线缆的束缚。同时，基于自研的插件式脑机接 口操作系统XessOs，该产品展现出极强的开放性，可无缝连接智能轮椅、家居乃至人形机器人，构建 起以用户意图为中心的"延伸躯体"生态。 本报讯(记者金婉霞)日前，在2025天桥脑科学研究院脑机接口与人工智能论坛上，上海脑虎科技有限公 司(以下简称"脑虎科技")发布了一项新成果：由其自主研发的国内首款、国际第二款内置电池"三全"(全 植入、全无线、全功能)脑机接口产品，成功完成首例临床试验。从临床数据来看，此次接受植入的高 位截瘫患者在术后1天可转入普通病 ...

因颈髓损伤而高位截瘫的中年人，仅凭意念，即可如臂使指地操控智能轮椅在小区遛弯，指挥机器狗作 为"身体延伸"取回外卖…… 这便是近日中国科学院脑科学与智能技术卓越创新中心赵郑拓、李雪团队(以下简称赵郑拓团队)联合复 旦大学附属华山医院及相关企业开展的第二例侵入式脑机接口临床试验的成果展示。研究团队采用高通 量无线侵入式脑机接口系统(WRS01)，使一位高位截瘫患者能够通过脑电信号稳定操控智能轮椅与机器 狗，在真实生活场景中实现自主移动与物品取用。 12月17日，在接受包括《每日经济新闻》记者在内的媒体记者采访时，赵郑拓表示，希望加速推动新品 临床转化与应用验证，让脑机接口技术真正走向临床落地应用，并以开放的心态与各类智能设备、应用 平台等合作，共同推动我国脑机接口技术高质量发展。 据赵郑拓团队透露，基于本次试验积累的数据与经验，研究团队于12月推出性能进一步提升的系统升级 版本(WRS02)，通道数增至256，WRS02的首例临床试验计划于近期开展。 患者靠脑机接口操控轮椅 在赵郑拓团队提供的一段视频中，这位患者坐上智能电动轮椅后，仿佛控制自己的肢体一般灵活。"我 想一下我要往左了""到这个地方……向右了"—— ...

Core Insights - The "14th Five-Year Plan" emphasizes the strategic development of six future industries, including quantum technology, biomanufacturing, hydrogen energy, and nuclear fusion energy, with a focus on transitioning from laboratory research to real-world applications [1][3] Group 1: Industry Development - A compact fusion energy experimental device (BEST) has entered the assembly phase, aiming for commercial application of fusion energy during the "14th Five-Year Plan" [3] - Significant breakthroughs in core technologies have been achieved, with several quantum sensors developed and applied in precision equipment across various fields [5] - The "artificial ocean carbon cycle system" in Shenzhen has operated stably for over 500 hours in real seawater, achieving over 70% CO2 capture efficiency, converting seawater CO2 into green raw materials for plastic production [7] Group 2: Market Potential - The market for embodied intelligence is expected to exceed 5 billion yuan by 2025, while the brain-computer interface market is projected to surpass 3.8 billion yuan, and the biomanufacturing industry is anticipated to approach 1 trillion yuan in total scale [11] Group 3: Policy and Support - The government will continue to strengthen policy support, focusing on the core tracks of the six future industries, creating development clusters, and nurturing specialized and innovative enterprises to form new trillion-yuan industry tracks [12]

Core Insights - The brain-computer interface (BCI) sector in China has made significant advancements, enabling paralyzed patients to control wheelchairs and robotic dogs through thought [1] - The market for brain-computer interfaces is projected to grow substantially, with estimates of 3.2 billion yuan in 2024 and reaching 6.14 billion yuan by 2028 in China [2] - The global BCI market is expected to grow from approximately 2.62 billion USD in 2024 to 12.4 billion USD by 2034, with a compound annual growth rate (CAGR) of 17.35% over the next decade [2] Industry Developments - The Chinese Academy of Sciences has achieved breakthroughs in invasive BCI technology, improving signal extraction efficiency by 15% to 20% in noisy environments [1] - The end-to-end latency for the new BCI system has been reduced to under 100 milliseconds, enhancing user experience compared to the natural physiological delay of 200 milliseconds [1] - The BCI industry is expected to benefit from policy support, technological innovation, and increased capital investment, leading to significant growth opportunities in healthcare and consumer markets [2] Company Highlights - Innovation Medical (002173) is involved in the only invasive BCI system in China that has reached Phase III clinical trials, comparable to Neuralink [3] - iFlytek (002230) leverages AI technology to develop BCI applications in collaboration with universities, expanding into the healthcare sector [3] - Lenovo (00992) has launched the world's first consumer-grade BCI headset, achieving a thought input speed of 12-15 words per minute with over 85% accuracy [3] - Sanbo Brain Science (301293) has conducted the first invasive BCI trial in China, providing new treatment options for stroke and paraplegic patients [3] - Gaode Infrared (002414) is developing a 65,000-channel implantable chip, significantly increasing channel density compared to Neuralink [3] - Tom Cat (300459) is exploring the intersection of AI and brain science in children's education and rehabilitation [4] - Hanwei Technology (300007) has a subsidiary involved in flexible electrodes and brain signal acquisition technology, showing potential for technology transfer [4]

Group 1: Industry Overview - The brain-computer interface (BCI) market in China is projected to reach 3.2 billion yuan in 2024 and is expected to grow to 6.14 billion yuan by 2028 [2] - The global BCI market is estimated to be approximately 2.62 billion USD in 2024, with a forecasted increase to 2.94 billion USD in 2025, and a potential growth to 12.4 billion USD by 2034, reflecting a compound annual growth rate (CAGR) of 17.35% over ten years [2] - The BCI industry is anticipated to benefit from dual drivers of policy and technology, presenting significant opportunities for growth [2] Group 2: Technological Advancements - Recent breakthroughs in invasive BCI technology have enabled a high-level paraplegic patient to control a smart wheelchair and robotic dog using brain signals, achieving a 15% to 20% improvement in brain control performance [1] - The new system developed by the research team has reduced end-to-end latency to under 100 milliseconds, which is lower than the physiological delay of 200 milliseconds in natural neural pathways, enhancing user experience [1] Group 3: Company Developments - Innovation Medical holds a 40% stake in Bole Medical and leads the only invasive BCI system (BCI-4000) in China that has entered Phase III clinical trials, comparable to Neuralink [3] - iFlytek leverages its AI technology to collaborate with universities on BCI applications, expanding into the healthcare sector [3] - Lenovo has launched the world's first consumer-grade BCI headset, "Lenovo Mind X1," which can achieve a typing speed of 12-15 characters per minute with over 85% accuracy, marking a significant step towards practical BCI applications [3] - Sanbo Neuroscience has completed China's first invasive BCI trial, providing new treatment options for stroke and paraplegic patients through wireless brain signal acquisition [3] - Gaode Infrared's subsidiary has developed a 65,000-channel implantable chip, which has a channel density 20 times that of Neuralink, enabling bidirectional information read/write capabilities [3] Group 4: Emerging Applications - Tom Cat is exploring the integration of BCI technology in children's education and rehabilitation, aiming to create a new model of "AI + brain science" [4] - Hanwei Technology's subsidiary is involved in flexible electrodes and brain signal acquisition technology, showing potential for technology commercialization [4]

扬子晚报网讯(记者吴佳笑)12月18日，2025长三角脑机接口平台建设暨产业创新发展会议在南通创新区举办。这场由南通市人民政府、长三角国家技术创 新中心联合主办的行业盛会，吸引了国内院士专家、投资机构及头部企业代表百余人齐聚一堂，共同为脑机接口产业发展献策，助力南通创新区产业生态 提质升级，推动长三角脑科学创新资源高效协同。 "脑机接口作为生命健康领域的新兴赛道，蕴藏着万亿级蓝海市场。"南通市副市长熊俊在致辞中表示，近年来南通锚定生命健康产业发展方向，通过集聚 龙头企业、搭建公共服务平台、打造特色产业园区等一系列举措，加速构建现代化产业体系。他指出，南通将以此次会议为契机，以创新区生命健康产业 为支点，深化产学研用合作，推动脑机接口技术从实验室走向临床一线，既成为科技突破的标杆，更化作惠及民生的福祉，在江海之滨书写脑科学与产业 融合发展的新篇章。 "临床研究是脑机接口落地应用的核心关键。"南开大学杰出教授、江苏集萃介入脑机信息技术研究所所长段峰表示，创新联合体的成立打通了技术研发与 产业转化的壁垒。他透露，团队将与江苏省人民医院开展深度合作，共建临床研究中心，围绕介入式脑机接口的原创研究成果，探索更多临床应用 ...